Targeting the HIV-protease in AIDS therapy: a current clinical perspective
- 8 March 2000
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
- Vol. 1477 (1-2) , 189-214
- https://doi.org/10.1016/s0167-4838(99)00273-3
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The Use of Combination Antiretroviral Therapy in HIV-Infected PatientsAnnals of Pharmacotherapy, 1999
- INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug DesignAnnual Review of Biophysics, 1998
- Clinically effective HIV-1 protease inhibitorsDrug Discovery Today, 1997
- Discovery and design of HIV protease inhibitors as drugs for treatment of aidsPublished by Elsevier ,1996
- The Structure and Function of the Aspartic ProteinasesAnnual Review of Biophysics, 1990
- Human immunodeficiency virus proteasePublished by Elsevier ,1989
- Active human immunodeficiency virus protease is required for viral infectivity.Proceedings of the National Academy of Sciences, 1988
- Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.Proceedings of the National Academy of Sciences, 1987
- A structural model for the retroviral proteasesNature, 1987
- Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirusNature, 1985